Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Oncotarget|October 25, 2016
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian familySimona De Summa, Michele Guida, Stefania Tommasi, et al.Plos One|December 2, 2014
Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutationVito Michele Garrisi, Sabino Strippoli, Simona De Summa, et al.Frontiers in Immunology|August 18, 2025
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot studySimona De Summa, Giuseppe De Palma, Veronica Ghini, et al.Journal of Translational Medicine|December 11, 2020
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanomaSabino Strippoli, Livia Fucci, Antonio Negri, et al.Frontiers in Immunology|May 27, 2024
Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, et al.Journal for Immunotherapy of Cancer|May 11, 2021
uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patientsLetizia Porcelli, Michele Guida, Simona De Summa, et al.Pigment Cell & Melanoma Research|August 20, 2016
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitorsMichele Guida, Sabino Strippoli, Anna Ferretta, et al.Scientific Reports|November 27, 2022
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patientsMaria Colomba Comes, Livia Fucci, Fabio Mele, et al.Frontiers in Cell and Developmental Biology|June 29, 2023
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoidsRoberta Di Fonte, Sabino Strippoli, Marianna Garofoli, et al.Cells|March 6, 2021
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic MelanomaSabino Strippoli, Annarita Fanizzi, Antonio Negri, et al.Pageof 6